trending Market Intelligence /marketintelligence/en/news-insights/trending/vqbwxauzidldh0srbwdmoa2 content esgSubNav
In This List

Compugen appoints chief medical officer

Blog

Insight Weekly: M&A outlook; US community bank margins; green hydrogen players' EU expansion

Blog

Global M&A by the Numbers: Q2 2022

Blog

Insight Weekly: US bank M&A; low refinancing eases rates impact; Texas crypto mining booms

Blog

Infographic 2022 Top Tech Trends Shaping Corporations


Compugen appoints chief medical officer

Compugen Ltd. appointed Henry Adewoye to the newly created role of chief medical officer, effective March 26.

Adewoye most recently served as clinical director in oncology clinical research at Gilead Sciences Inc.

Tel Aviv-based Compugen is a therapeutic discovery and development company working to identify novel drug targets and develop therapeutics in the field of cancer immunotherapy.